In cases of relapsed CNSL, primary lymphoma locations such as testes, breast, and uterine DLBCL have a high prevalence of the non-germinal center B-cell (non-GCB) phenotype and the MYD88/CD79B-mutated genotype with a more reserved prognosis [13]. The gene discussed is MYD88; the disease is lymphoma.